Mulhouse, France (July 26, 2019) – FH Ortho, a manufacturer of orthopedic devices and instruments for surgeons around the world, announced it has received approval from the Pharmaceuticals and Medical Devices Agency of Japan to market the Arrow^® Prime Anatomic Shoulder System to treat complex fractured shoulder reconstructions and total joint replacements resulting from wear or trauma.  “The approval of Arrow Prime in Japan represents another exciting opportunity to further grow our presence in the global market” said Jean-Marc Idier, President Group FH Ortho. “Our goal is to design innovative implants that are simple and easy to use with reproducible results for a broad range of patients and I believe we have achieved this with the Arrow Prime Shoulder System.”

More than 24,000 cases have been performed worldwide with the Arrow Shoulder System since 2003, with over 15 years of clinical data.

> Read more about the Arrow Prime Shoulder System